Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases (NDDs) such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis epitomize a class of insidious and relentless neurological conditions that are difficult to cure. Conventional therapeutic regimens often fail due to the late onset of symptoms, which occurs well after irreversible neurodegeneration has begun. The integrity of the blood-brain barrier (BBB) further impedes efficacious drug delivery to the central nervous system, presenting a formidable challenge in the pharmacological treatment of NDDs. Recent scientific inquiries have shifted focus toward the peripheral biological systems, investigating their influence on central neuropathology through the lens of extracellular vesicles (EVs). These vesicles, distinguished by their ability to breach the BBB, are emerging as dual operatives in the context of NDDs, both as conveyors of pathogenic entities and as prospective vectors for therapeutic agents. This review critically summarizes the burgeoning evidence on the role of extracerebral EVs, particularly those originating from bone, adipose tissue, and gut microbiota, in modulating brain pathophysiology. It underscores the duplicity potential of peripheral EVs as modulators of disease progression and suggests their potential as novel vehicles for targeted therapeutic delivery, positing a transformative impact on the future landscape of NDD treatment strategies. Search strategy A comprehensive literature search was conducted using PubMed, Web of Science, and Scopus from January 2000 to December 2023. The search combined the following terms using Boolean operators: “neurodegenerative disease” OR “Alzheimer’s disease” OR “Parkinson’s disease” OR “Amyotrophic lateral sclerosis” AND “extracellular vesicles” OR “exosomes” OR “outer membrane vesicles” AND “drug delivery systems” AND “blood-brain barrier”. MeSH terms were employed when searching PubMed to refine the results. Studies were included if they were published in English, involved human subjects, and focused on the peripheral origins of EVs, specifically from bone, adipose tissue, and gut microbiota, and their association with related diseases such as osteoporosis, metabolic syndrome, and gut dysbiosis. Articles were excluded if they did not address the role of EVs in the context of NDDs or did not discuss therapeutic applications. The titles and abstracts of retrieved articles were screened using a dual-review process to ensure relevance and accuracy. The reference lists of selected articles were also examined to identify additional relevant studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“extracellular vesicles derived from adipose mesenchymal stem cells and umbilical cord mesenchymal stem cells can improve a wide range of age-related phenotypes and delay the ageing process in aged mice.440–442”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [442]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox
Wang, Z.-X., Luo, Z.-W., Li, F.-X.-Z., Cao, J., Rao, S.-S., Liu, Y.-W., Wang, Y.-Y., Zhu, G.-Q., Gong, J.-S., Zou, J.-T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29191-x · Cited by 159 · cited 1×
“Beyond their traditional confines, osteocytes reach into systemic physiology through their secretome, influencing distal organ functions [76, 78, 79].”
BackgroundSelf-citationRetractedZhao, Y., Haney, M. J., Gupta, R., Bohnsack, J. P., He, Z., Kabanov, A. V., & Batrakova, E. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106867 · Cited by 145
RetractedThe biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369 · cited 1×
“Their repertoire extends beyond mere waste disposal to orchestrating physiological and pathological processes, facilitated by their capacity to breach the blood-brain barrier (BBB) and to mediate crosstalk between the CNS and peripheral tissues [7, 8, 11–13].”
BackgroundDementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072 · cited 1×
“Despite extensive research, therapeutic strategies targeting these neuropathological features, specifically aimed at the clearance of Aβ or tau, have not yet resulted in significant clinical benefit [19].”
BackgroundScheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 3×
“DC-derived EVs, pivotal in the orchestration of immune responses, also partake in antigen presentation, a function that might be exploit-able for disease-modifying strategies in NDDs [137–139].”
BackgroundBloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Mathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737 · cited 1×
“These vesicles, encompassing both exosomes (30– 100 nm) derived from endosomal compartments and the more heterogeneous ectosomes (50–1000 nm), encapsulate a microcosm of the cellular interior, carrying nucleic acids, proteins, lipids, and metabolites across biological frontiers [8–10].”
BackgroundExtracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571 · cited 1×
“These naturally occurring nanocarriers harbor the intrinsic ability to encapsulate and convey bioactive molecules—proteins, lipids, and nucleic acids—reflec-tive of their cells of origin, thus preserving the potential for therapeutic modulation [127].”
BackgroundAgeing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 1×
“These disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), not only precipitate profound neurological impairment but also impart considerable socioeconomic strain as life expectancies elon-gate globally [1].”
BackgroundBonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 1×
“His-torically relegated to the role of mechanical placeholders within bone, osteocytes are now recognized as dynamic endocrine players, orchestrating bone remodeling and mineral metabolism [77].”
BackgroundExosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · cited 2×
“For PD, catalase and dopamine have been loaded in EVs to attenuate neuroinflammation and replenish neurotransmitter levels respectively [138, 154].”
BackgroundExtracellular vesicles as a next-generation drug delivery platform
Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00931-2 · Cited by 1,948 · cited 1×
“This facilitates a targeted delivery mechanism that is both specific to the neural tissue and favorable in terms of reduced systemic toxicity [128, 147, 148].”
BackgroundExtracellular vesicles as drug delivery systems: Why and how?
Elsharkasy, O. M., Nordin, J. Z., Hagey, D. W., de Jong, O. G., Schiffelers, R. M., Andaloussi, S. E., & Vader, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.004 · Cited by 1,197 · cited 1×
“Polymers like polycaprolactone (PCL), polylactic acid (PLA), and poly(lactic-co-glycolic acid) (PLGA), despite their versatility, are often challenged by suboptimal drug loading efficiencies and potential localized immune responses [129, 146].”
BackgroundParkinson’s disease: etiopathogenesis and treatment
Jankovic, J., & Tan, E. K. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322338 · Cited by 1,169 · cited 1×
“The pathognomonic feature of PD is the presence of Lewy bodies, and neuronal cytoplasmic inclusions predominantly composed of misfolded α-synuclein (α-syn), which mark the neuronal landscape of the disease [27].”
BackgroundFeldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01272-7 · Cited by 1,129
cGAS–STING drives ageing-related inflammation and neurodegeneration
Gulen, M. F., Samson, N., Keller, A., Schwabenland, M., Liu, C., Glück, S., Thacker, V. V., Favre, L., Mangeat, B., Kroese, L. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06373-1 · Cited by 1,104 · cited 1×
“It encompasses a more complex scenario where peripheral dysregulation, mediated through EVs and other molecular conduits, orchestrates a detrimental cross-talk that may precipitate or per-petuate neurodegeneration [16].”
BackgroundAn Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042 · cited 1×
“Beyond their traditional confines, osteocytes reach into systemic physiology through their secretome, influencing distal organ functions [76, 78, 79].”
BackgroundAkbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946 · cited 1×
“Strains of Lactobacillus and Bifidobacterium , for instance, have been noted to ameliorate cognitive deficits in AD models [110, 111], and Akkermansia muciniphila has demonstrated potential in alleviating symptoms in neurodegenerative mouse models [112, 113].”
BackgroundThe Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857 · cited 1×
“Disturbances in the microbiota, or dysbiosis, triggered by factors like antibiotics, stress, or infection, disrupt this communication and may lead to a permeabilized gut barrier, allowing for the systemic dissemination of pro-inflammatory agents [104].”
BackgroundExosomes and other extracellular vesicles in host–pathogen interactions
Schorey, J. S., Cheng, Y., Singh, P. P., & Smith, V. L. (2015) · EMBO reports · doi:10.15252/embr.201439363 · Cited by 727
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Kleimeyer, C., Moresi, C., Harnik, Y., Zur, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1443-5 · Cited by 700 · cited 1×
“Strains of Lactobacillus and Bifidobacterium , for instance, have been noted to ameliorate cognitive deficits in AD models [110, 111], and Akkermansia muciniphila has demonstrated potential in alleviating symptoms in neurodegenerative mouse models [112, 113].”
BackgroundThe β-Secretase BACE1 in Alzheimer’s Disease
Hampel, H., Vassar, R., De Strooper, B., Hardy, J., Willem, M., Singh, N., Zhou, J., Yan, R., Vanmechelen, E., De Vos, A., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.001 · Cited by 694
The endocrine function of adipose tissues in health and cardiometabolic disease
Scheja, L., & Heeren, J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0230-6 · Cited by 663 · cited 1×
“As the primary energy reservoir and an endocrine powerhouse, adipose tissue orchestrates a symphony of hormones and bioactive molecules, profoundly influencing peripheral and central processes [84].”
BackgroundThe dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616 · cited 1×
“The discerning permeability of BBB is pivotal for neural homeostasis but simultaneously poses significant impediments to the pharmacotherapy of neurodegenerative disorders, thwarting the passage of most therapeutic agents [129, 130].”
BackgroundMeng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 592 · cited 2×
“This facilitates a targeted delivery mechanism that is both specific to the neural tissue and favorable in terms of reduced systemic toxicity [128, 147, 148].”
BackgroundBanks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124407 · Cited by 561 · cited 1×
“A recent investigative delineated the trans-BBB trafficking of various EV populations, discerning a spectrum of permeability across mouse, human, neoplastic, and non-neoplastic cellular lineages, thereby illuminating the differential crossing efficacies that could be harnessed therapeutically [131].”
BackgroundDopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease
Qu, M., Lin, Q., Huang, L., Fu, Y., Wang, L., He, S., Fu, Y., Yang, S., Zhang, Z., Zhang, L., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.035 · Cited by 543 · cited 1×
“For PD, catalase and dopamine have been loaded in EVs to attenuate neuroinflammation and replenish neurotransmitter levels respectively [138, 154].”
Robling, A. G., & Bonewald, L. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034332 · Cited by 539 · cited 2×
“Osteocytes extend an intricate network of dendritic processes (on average 50), similar to neuronal dendrites, facilitating intercellular communication through gap junctions and canalicular conduits within the mineralized bone matrix [76].”
BackgroundStuendl, A., Kunadt, M., Kruse, N., Bartels, C., Moebius, W., Danzer, K. M., Mollenhauer, B., & Schneider, A. (2016) · Brain · doi:10.1093/brain/awv346 · Cited by 428
The progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419 · cited 1×
“The gut-brain axis (GBA) epitomizes this bidirectional communication, with the gut microbiota acting as a key mediator [102, 103].”
BackgroundExtracellular vesicles: novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos, D., Albuquerque, P. R., Carmona, V., Perfeito, R., Nobre, R. J., & Pereira de Almeida, L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.001 · Cited by 418
Identification of storage conditions stabilizing extracellular vesicles preparations
Görgens, A., Corso, G., Hagey, D. W., Jawad Wiklander, R., Gustafsson, M. O., Felldin, U., Lee, Y., Bostancioglu, R. B., Sork, H., Liang, X., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12238 · Cited by 413 · cited 1×
“The structural integrity of EVs allows for prolonged storage at cryogenic temperatures with minimal degradation, ensuring the stability of encapsulated therapeutic agents ranging from enzymes to nucleic acids [148, 149].”
BackgroundThe involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane, Tatiani, Francielle, Michelle, & Alexandra (2015) · Aging and disease · doi:10.14336/ad.2015.0825 · Cited by 407 · cited 1×
“Notably, diets rich in fats and sugars precipitate declines in brain-derived neurotrophic factor (BDNF) expression [90, 91], which is essential for neuronal survival and synaptic integrity.”
BackgroundProbiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice
Yang, X., Yu, D., Xue, L., Li, H., & Du, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.001 · Cited by 407 · cited 1×
“Strains of Lactobacillus and Bifidobacterium , for instance, have been noted to ameliorate cognitive deficits in AD models [110, 111], and Akkermansia muciniphila has demonstrated potential in alleviating symptoms in neurodegenerative mouse models [112, 113].”
BackgroundImmune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 388 · cited 1×
“Central neuroinflammation is recognized as a cardinal pathological feature, contributing to the relentless neuronal attrition observed in ALS [37].”
BackgroundCui, G.-H., Guo, H.-D., Li, H., Zhai, Y., Gong, Z.-B., Wu, J., Liu, J.-S., Dong, Y.-R., Hou, S.-X., & Liu, J.-R. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0150-2 · Cited by 347 · cited 1×
“These bioengineered MSC-RVG-EVs downregulated pro-inflammatory cytokines, upregulated anti-inflammatory IL-10, and importantly, improved cognitive function, which is a significant therapeutic outcome [142].”
BackgroundOu, Z., Deng, L., Lu, Z., Wu, F., Liu, W., Huang, D., & Peng, Y. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0115-8 · Cited by 328
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation
Verderio, C., Muzio, L., Turola, E., Bergami, A., Novellino, L., Ruffini, F., Riganti, L., Corradini, I., Francolini, M., Garzetti, L., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23627 · Cited by 326 · cited 1×
“They are implicated in various mechanisms, such as modulating the activation state of microglia, the resident immune cells of the brain, which have been associated with the pathogenesis of diseases like multiple sclerosis (MS) and AD [73, 74].”
BackgroundWang, H., Sui, H., Zheng, Y., Jiang, Y., Shi, Y., Liang, J., & Zhao, L. (2019) · Nanoscale · doi:10.1039/c9nr01255a · Cited by 324
Propagation of Protein Aggregation in Neurodegenerative Diseases
Vaquer-Alicea, J., & Diamond, M. I. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045049 · Cited by 310 · cited 1×
“The pathogenesis of NDDs has been predominantly attributed to CNS intrinsic factors, with hallmark neuropathological features such as amyloid-β (Aβ) plaques, hyperphosphorylated tau, and misfolded alpha-synuclein (α-syn) driving the research narrative [3].”
BackgroundCD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Williams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Gallups, N. J., Standaert, D. G., & Harms, A. S. (2021) · Brain · doi:10.1093/brain/awab103 · Cited by 306 · cited 1×
“The crosstalk between the peripheral immune system and the CNS is a critical component of neuroinflammatory responses in neurodegeneration [71, 72].”
BackgroundLiu, S., Fan, M., Xu, J.-X., Yang, L.-J., Qi, C.-C., Xia, Q.-R., & Ge, J.-F. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02393-2 · Cited by 296 · cited 2×
“These EVs possess the functional components derived from their progenitor cells, carrying inherent targeting properties and the capacity to transverse biological barriers [62, 63].”
BackgroundMitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure
Wang, Y., Xu, E., Musich, P. R., & Lin, F. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13116 · Cited by 294 · cited 1×
“Traditional paradigms attribute these phenotypes to an array of cellular malfunctions, including compromised mitochondrial efficacy, oxidative stress, and defective autophagic processes [2–6].”
BackgroundThe neuroimmune axis of Alzheimer’s disease
Jorfi, M., Maaser-Hecker, A., & Tanzi, R. E. (2023) · Genome Medicine · doi:10.1186/s13073-023-01155-w · Cited by 292 · cited 1×
“Moreover, systemic inflammation and peripheral metabolic dysfunctions are increasingly recognized as key modulators of CNS pathology, suggesting that peripheral homeostatic alterations might be upstream events in NDD development [15].”
BackgroundLeptin and brain–adipose crosstalks
Caron, A., Lee, S., Elmquist, J. K., & Gautron, L. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.7 · Cited by 284
Upadhya, R., Zingg, W., Shetty, S., & Shetty, A. K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.017 · Cited by 282 · cited 1×
“They are suspected couriers of pathogenic cargo, with a putative role in the dissemination of neurotoxic elements toward motor neurons (MNs) [40, 42].”
BackgroundMicroglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
Joshi, P., Turola, E., Ruiz, A., Bergami, A., Libera, D. D., Benussi, L., Giussani, P., Magnani, G., Comi, G., Legname, G., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.180 · Cited by 275 · cited 1×
“In models of AD, for instance, myeloid-derived EVs have been shown to enhance the phagocytic activity of microglia towards Aβ aggregates, indicating a potential for therapeutic modulation of innate immune responses [75].”
BackgroundRole of metabolism in neurodegenerative disorders
Procaccini, C., Santopaolo, M., Faicchia, D., Colamatteo, A., Formisano, L., de Candia, P., Galgani, M., De Rosa, V., & Matarese, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.018 · Cited by 258
Emerging mRNA technologies: delivery strategies and biomedical applications
Xiao, Y., Tang, Z., Huang, X., Chen, W., Zhou, J., Liu, H., Liu, C., Kong, N., & Tao, W. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00617g · Cited by 255 · cited 1×
“Mirroring the swift advancements in mRNA-based therapeutics for infectious diseases and oncology, the prospective integration of mRNA drugs into EV platforms for NDD treat-ment holds immense promise [159].”
BackgroundWang, J., Li, L., Zhang, Z., Zhang, X., Zhu, Y., Zhang, C., & Bi, Y. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.004 · Cited by 250 · cited 1×
“EVs from such compromised states can induce cognitive decline and synaptic deficits in otherwise healthy recipients, implicating miRNAs like miR-9-3p in the dysregulation of neuronal insulin signaling [99].”
BackgroundExtracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and Strength
Liu, J., Chen, C., Liu, Z., Luo, Z., Rao, S., Jin, L., Wan, T., Yue, T., Tan, Y., Yin, H., et al. (2021) · Advanced Science · doi:10.1002/advs.202004831 · Cited by 249 · cited 1×
“The intricate ecosystem of the human gut microbiota is a pivotal contributor to homeostasis, extending its influence beyond the gastrointestinal tract to modulate immune, neurological, and metabolic functions [101].”
BackgroundSelf-citationQi, Y., Guo, L., Jiang, Y., Shi, Y., Sui, H., & Zhao, L. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1762262 · Cited by 239 · cited 1×
“Similarly, bioactive compounds such as quercetin and curcumin, as well as protein modulators like tyrosine phosphatase-2 (SHP2), have been efficiently packaged within EVs, providing a therapeutic thrust against hyperphosphorylated tau and mitochondrial dysfunction associated with AD [151–153].”
BackgroundHarms, A. S., Thome, A. D., Yan, Z., Schonhoff, A. M., Williams, G. P., Li, X., Liu, Y., Qin, H., Benveniste, E. N., & Standaert, D. G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.010 · Cited by 236 · cited 1×
“The crosstalk between the peripheral immune system and the CNS is a critical component of neuroinflammatory responses in neurodegeneration [71, 72].”
BackgroundParkinson’s: a syndrome rather than a disease?
Titova, N., Padmakumar, C., Lewis, S. J. G., & Chaudhuri, K. R. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1667-6 · Cited by 233 · cited 1×
“The classical view of PD as a disease confined to the CNS has been challenged by revelations of widespread α-syn deposition, not just in the brain but also in peripheral tissues including the intestine, pancreas, heart, salivary glands, and skin [28–30].”
BackgroundBlood-derived amyloid-β protein induces Alzheimer’s disease pathologies
Bu, X.-L., Xiang, Y., Jin, W.-S., Wang, J., Shen, L.-L., Huang, Z.-L., Zhang, K., Liu, Y.-H., Zeng, F., Liu, J.-H., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.204 · Cited by 229 · cited 1×
“It has been posited that peripheral cells are capable of producing Aβ, which could instigate or exacerbate cerebral amyloidosis [20, 21].”
BackgroundSelf-citationExosomes based strategies for brain drug delivery
Rehman, F. U., Liu, Y., Zheng, M., & Shi, B. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2022.121949 · Cited by 229 · cited 4×
“Their structural bilipid membrane composition not only ensures the integrity of their molecular cargo but also facilitates their navigation across the biological moat that is the BBB, a feature that is indispensable for the targeted delivery of therapeutics to the CNS [128].”
BackgroundInfluentialde Godoy, M. A., Saraiva, L. M., de Carvalho, L. R. P., Vasconcelos-dos-Santos, A., Beiral, H. J. V., Ramos, A. B., Silva, L. R. D. P., Leal, R. B., Monteiro, V. H. S., Braga, C. V., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807180 · Cited by 214
Shen, H., Guan, Q., Zhang, X., Yuan, C., Tan, Z., Zhai, L., Hao, Y., Gu, Y., & Han, C. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109884 · Cited by 201
Zhang, J., Buller, B. A., Zhang, Z. G., Zhang, Y., Lu, M., Rosene, D. L., Medalla, M., Moore, T. L., & Chopp, M. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113895 · Cited by 191 · cited 1×
“These EVs are armed with regenerative cargo, growth factors, anti-inflammatory cytokines, and neurotrophic molecules, that endorse neuronal survival and plasticity [46, 47].”
BackgroundLee, K.-E., Kim, J.-K., Han, S.-K., Lee, D. Y., Lee, H.-J., Yim, S.-V., & Kim, D.-H. (2020) · Microbiome · doi:10.1186/s40168-020-00881-2 · Cited by 188 · cited 1×
“Moreover, neurotoxic EVs from pathogens, like Pseudomonas aeruginosa, Paenalcaligenes hominis , and Aggregatibacter actinomycetemcomitans , contain components such as lipopolysaccharides (LPS) that can invoke a robust immune response in the CNS [115, 121, 122].”
BackgroundThe impact of obesity on neurodegenerative diseases.
Mazon, J. N., de Mello, A. H., Ferreira, G. K., & Rezin, G. T. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.002 · Cited by 185 · cited 1×
“Dysfunction in adipose tissue, marked by altered secretion of adipokines such as leptin and adiponectin, emerges as a pivotal factor in NDD etiology [85– 88].”
BackgroundMorrell, A. E., Brown, G. N., Robinson, S. T., Sattler, R. L., Baik, A. D., Zhen, G., Cao, X., Bonewald, L. F., Jin, W., Kam, L. C., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0007-x · Cited by 184 · cited 1×
“For instance, mechanical loading has been shown to revitalize osteocytes and enhance the secretion of EVs derived from them [164, 165].”
BackgroundLi, Y., Liu, B., Zhao, T., Quan, X., Han, Y., Cheng, Y., Chen, Y., Shen, X., Zheng, Y., & Zhao, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01828-z · Cited by 173
Kuo, Y.-M., Kokjohn, T. A., Watson, M. D., Woods, A. S., Cotter, R. J., Sue, L. I., Kalback, W. M., Emmerling, M. R., Beach, T. G., & Roher, A. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64947-4 · Cited by 167
Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy
Chen, M.-L., Hong, C.-G., Yue, T., Li, H.-M., Duan, R., Hu, W.-B., Cao, J., Wang, Z.-X., Chen, C.-Y., Hu, X.-K., et al. (2021) · Theranostics · doi:10.7150/thno.47408 · Cited by 163
Self-citationJahangard, Y., Monfared, H., Moradi, A., Zare, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00564 · Cited by 162 · cited 1×
“Further, miRNA-enriched EVs have been shown to exert neuroprotective effects, with miR-29 and miR-22 variants downregulating pathological Aβ production and inflammatory cascades in AD models [156, 157].”
BackgroundThe immunogenicity of dendritic cell-derived exosomes
Quah, B., & O'Neill, H. C. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.05.002 · Cited by 158 · cited 1×
“Of particular interest are EVs from immature DCs, which are proficient in the release of EVs devoid of T-cell co-stimulatory molecules, such as major histocompatibility complex class II (MHC-II), thereby proffering an immunologically quiescent profile for therapeutic purposes [140].”
BackgroundPeripheral monocytes are functionally altered and invade the CNS in ALS patients
Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154
Choi, J., Kim, Y.-K., & Han, P.-L. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.2.158 · Cited by 154 · cited 1×
“EVs from Lactobacillus plantarum , for example, have elicited antidepressant effects and counteracted amyloid-beta induced neuropathology in experimental models [123, 124].”
BackgroundProbiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 151 · cited 1×
“Probiotics can also help patients with PD to result in beneficial impacts on movement disorders and constipation [114].”
BackgroundXie, J., Cools, L., Van Imschoot, G., Van Wonterghem, E., Pauwels, M. J., Vlaeminck, I., De Witte, C., EL Andaloussi, S., Wierda, K., De Groef, L., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12306 · Cited by 149 · cited 1×
“For instance, Helicobacter pylori ( HP ) EVs can breach the BBB and provoke neuroinflammation through mechanisms involving glial cell activation and complement pathway signaling, potentially exacerbating amyloidogenic pathology [119, 120].”
BackgroundXu, F., Wu, Y., Yang, Q., Cheng, Y., Xu, J., Zhang, Y., Dai, H., Wang, B., Ma, Q., Chen, Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207107 · Cited by 147 · cited 1×
“Similarly, bioactive compounds such as quercetin and curcumin, as well as protein modulators like tyrosine phosphatase-2 (SHP2), have been efficiently packaged within EVs, providing a therapeutic thrust against hyperphosphorylated tau and mitochondrial dysfunction associated with AD [151–153].”
BackgroundBonafede, R., Turano, E., Scambi, I., Busato, A., Bontempi, P., Virla, F., Schiaffino, L., Marzola, P., Bonetti, B., & Mariotti, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103651 · Cited by 146 · cited 1×
“Moreover, in animal models of ALS, AD-MSC-derived EVs home to affected neural regions, attenuating motor neuron degeneration and glial activation [97].”
BackgroundElia, C. A., Tamborini, M., Rasile, M., Desiato, G., Marchetti, S., Swuec, P., Mazzitelli, S., Clemente, F., Anselmo, A., Matteoli, M., et al. (2019) · Cells · doi:10.3390/cells8091059 · Cited by 139
Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication
Cuesta, C. M., Guerri, C., Ureña, J., & Pascual, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084235 · Cited by 131 · cited 1×
“Moreover, neurotoxic EVs from pathogens, like Pseudomonas aeruginosa, Paenalcaligenes hominis , and Aggregatibacter actinomycetemcomitans , contain components such as lipopolysaccharides (LPS) that can invoke a robust immune response in the CNS [115, 121, 122].”
BackgroundAdiponectin and Cognitive Decline
Rizzo, M. R., Fasano, R., & Paolisso, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062010 · Cited by 128 · cited 2×
“Dysfunction in adipose tissue, marked by altered secretion of adipokines such as leptin and adiponectin, emerges as a pivotal factor in NDD etiology [85– 88].”
BackgroundGiunti, D., Marini, C., Parodi, B., Usai, C., Milanese, M., Bonanno, G., Kerlero de Rosbo, N., & Uccelli, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81039-4 · Cited by 125 · cited 1×
“…the therapeutic potential of EVs has been glimpsed in studies where EVs from peripheral mesenchymal stromal cells exert immunomodulatory effects, possibly mediated by microRNAs targeting microglial cells, thus offering a beacon of hope in the modulation of neuroinflammation in ALS [44].”
BackgroundJeske, R., Liu, C., Duke, L. C., Castro, M. L. C., Muok, L., Arthur, P., Singh, M. S., Jung, S., Sun, L. J., & Li, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.004 · Cited by 123 · cited 1×
“Jeske et al. reported that culturing human MSCs (hMSCs) in a 3D dynamic bioreactor significantly boosted the yield of EVs and enhanced the profile of their therapeutic cargo, suggesting that bioprocessing strategies can be pivotal in optimizing EV-based therapies for clinical applications [144].”
BackgroundChiot, A., Zaïdi, S., Iltis, C., Ribon, M., Berriat, F., Schiaffino, L., Jolly, A., de la Grange, P., Mallat, M., Bohl, D., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00718-z · Cited by 122
Outer membrane vesicles enhance tau phosphorylation and contribute to cognitive impairment
Wei, S., Peng, W., Mai, Y., Li, K., Wei, W., Hu, L., Zhu, S., Zhou, H., Jie, W., Wei, Z., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29362 · Cited by 120 · cited 1×
“These bacterial EVs have emerged as novel communicators within the GBA, traversing to the host brain via circulatory or neural pathways [117, 118].”
BackgroundMeng, Q., Tai, W., Tian, M., Zhuang, X., Pan, Y., Lai, J., Xu, Y., Xu, Z., Li, M., Zhao, G., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg3277 · Cited by 118 · cited 1×
“The landscape of therapeutic strategies for NDDs is on the cusp of a significant paradigm shift with the advent of EVs as drug delivery systems (DDS) [145].”
BackgroundAmyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function
Li, S., Liu, B., Zhang, L., & Rong, L. (2014) · Bone · doi:10.1016/j.bone.2014.01.010 · Cited by 117
The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease
Gibbons, C. H., Garcia, J., Wang, N., Shih, L. C., & Freeman, R. (2016) · Neurology · doi:10.1212/wnl.0000000000002919 · Cited by 115
Zhai, L., Shen, H., Sheng, Y., & Guan, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16787 · Cited by 114 · cited 1×
“Further, miRNA-enriched EVs have been shown to exert neuroprotective effects, with miR-29 and miR-22 variants downregulating pathological Aβ production and inflammatory cascades in AD models [156, 157].”
BackgroundAgosta, F., Dalla Libera, D., Spinelli, E. G., Finardi, A., Canu, E., Bergami, A., Bocchio Chiavetto, L., Baronio, M., Comi, G., Martino, G., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24235 · Cited by 113 · cited 1×
“They are implicated in various mechanisms, such as modulating the activation state of microglia, the resident immune cells of the brain, which have been associated with the pathogenesis of diseases like multiple sclerosis (MS) and AD [73, 74].”
BackgroundOsteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice
Kyrkanides, S., Tallents, R. H., Miller, J.-N. H., Olschowka, M. E., Johnson, R., Yang, M., Olschowka, J. A., Brouxhon, S. M., & O'Banion, M. K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-112 · Cited by 113 · cited 1×
“The attrition of osteocellular vitality, whether through apoptotic demise or dormancy, appears to coincide with a decline in the supportive secretome, implicating bone health as a critical factor in the etiopathogenesis of NDDs [80–82].”
BackgroundSun, M., Ma, K., Wen, J., Wang, G., Zhang, C., Li, Q., Bao, X., & Wang, H. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190872 · Cited by 113 · cited 1×
“This imbalance in homeostasis can lead to infection by opportunistic pathogenic bacteria and increased BBB permeability, thus promoting neuroinflammation and the accumulation of neurotoxic misfolded proteins in the CNS [106–109].”
BackgroundVisceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells
Guo, D.-H., Yamamoto, M., Hernandez, C. M., Khodadadi, H., Baban, B., & Stranahan, A. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci126078 · Cited by 112 · cited 1×
“Proinflammatory adipokines further exacerbate neuroinflammation, disrupting CNS homeostasis [88, 92].”
BackgroundHuang, H.-K., Wang, J.-H., Lei, W.-Y., Chen, C.-L., Chang, C.-Y., & Liou, L.-S. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.11.331 · Cited by 106 · cited 1×
“This imbalance in homeostasis can lead to infection by opportunistic pathogenic bacteria and increased BBB permeability, thus promoting neuroinflammation and the accumulation of neurotoxic misfolded proteins in the CNS [106–109].”
BackgroundYin, T., Liu, Y., Ji, W., Zhuang, J., Chen, X., Gong, B., Chu, J., Liang, W., Gao, J., & Yin, Y. (2023) · Theranostics · doi:10.7150/thno.81860 · Cited by 98 · cited 1×
“It is posited that transcellular transport of EVs ensues via endocytic uptake by BMECs, an event capable of instigating phenotypic alterations within these cells and modulating the selective permeability of BBB [25, 132, 133].”
BackgroundAlzheimer’s disease: as it was in the beginning
Kozlov, S. O., Afonin, A. М., Evsyukov, I., & Бондаренко, А. Б. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0006 · Cited by 95 · cited 1×
“AD, characterized by a profound decline in cognitive faculties and the most prevalent form of dementia, presents a formidable challenge to the medical community [17].”
BackgroundAdipo-glial signaling mediates metabolic adaptation in peripheral nerve regeneration
Sundaram, V. K., Schütza, V., Schröter, N. H., Backhaus, A., Bilsing, A., Joneck, L., Seelbach, A., Mutschler, C., Gomez-Sanchez, J. A., Schäffner, E., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.017 · Cited by 94 · cited 1×
“The interplay between adipose tissue and the CNS extends far beyond mere energy storage, engaging in a complex dialogue critical for maintaining metabolic and neurologic homeostasis [83].”
BackgroundForostyak, S., Homola, A., Turnovcova, K., Svitil, P., Jendelova, P., & Sykova, E. (2014) · Stem Cells · doi:10.1002/stem.1812 · Cited by 92 · cited 1×
“Furthermore, the intrathecal introduction of these cells in a rodent model of ALS has led to significant disease modification, enhancing motor function and prolonging lifespan [61].”
BackgroundPark, A.-M., & Tsunoda, I. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00224-8 · Cited by 92 · cited 1×
“For instance, Helicobacter pylori ( HP ) EVs can breach the BBB and provoke neuroinflammation through mechanisms involving glial cell activation and complement pathway signaling, potentially exacerbating amyloidogenic pathology [119, 120].”
BackgroundGao, W., Li, F., Liu, L., Xu, X., Zhang, B., Wu, Y., Yin, D., Zhou, S., Sun, D., Huang, Y., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.06.001 · Cited by 90 · cited 1×
“It is posited that transcellular transport of EVs ensues via endocytic uptake by BMECs, an event capable of instigating phenotypic alterations within these cells and modulating the selective permeability of BBB [25, 132, 133].”
BackgroundGeng, Y., Long, X., Zhang, Y., Wang, Y., You, G., Guo, W., Zhang, Y., Zhang, Y., Cheng, X., Yuan, Z., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04461-4 · Cited by 90
Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models
La Vitola, P., Balducci, C., Baroni, M., Artioli, L., Santamaria, G., Castiglioni, M., Cerovic, M., Colombo, L., Caldinelli, L., Pollegioni, L., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12644 · Cited by 88 · cited 1×
“This cascade not only accentuates the neurodegenerative process but also magnifies the deleterious impact of α-syn oligomers, further compromising neuronal integrity and amplifying motor and non-motor deficits in PD models [33].”
BackgroundLi, Q., Niu, X., Yi, Y., Chen, Y., Ji, Y., Zhang, J., Li, H., Xia, Y., Wang, Y., & Deng, Z. (2022) · ACS Nano · doi:10.1021/acsnano.2c10824 · Cited by 88 · cited 1×
“This is exemplified by studies demonstrating that inducible pluripotent stem cell-derived small EVs (iPSC-sEVs) appear to counteract senescence in the BBB, offering cytoprotection in ischemic cerebrovascular insults [134].”
BackgroundJiang, Y., Wang, Z., Liu, X., Wan, M., Liu, Y., Jiao, B., Liao, X., Luo, Z., Wang, Y., Hong, C., et al. (2022) · Advanced Science · doi:10.1002/advs.202105316 · Cited by 86 · cited 4×
“Dysfunctional osteocyte-derived EVs, in the environment of diseases such as OP, may lose their neuroprotective attributes or, worse, transport pathological molecules that could precipitate or aggravate NDDs [47].”
BackgroundInfluentialSelf-citationZhou, R., Zhou, H., Rui, L., & Xu, J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140812115818 · Cited by 85
Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings
Adler, C. H., Dugger, B. N., Hentz, J. G., Hinni, M. L., Lott, D. G., Driver‐Dunckley, E., Mehta, S., Serrano, G., Sue, L. I., Duffy, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26476 · Cited by 85 · cited 1×
“The classical view of PD as a disease confined to the CNS has been challenged by revelations of widespread α-syn deposition, not just in the brain but also in peripheral tissues including the intestine, pancreas, heart, salivary glands, and skin [28–30].”
BackgroundHe, S., Wang, Q., Chen, L., He, Y. J., Wang, X., & Qu, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04638-x · Cited by 85
Wang, X., & Yang, G. (2021) · Cell Biology International · doi:10.1002/cbin.11522 · Cited by 83 · cited 1×
“These vesicles carry the upregulation of brain-derived neurotrophic factor (BDNF) and neprilysin (NEP), a critical Aβ-degrading enzyme, simultaneously attenuating neuroinflammatory processes [62, 65].”
BackgroundCharacterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease
Funk, N., Wieghofer, P., Grimm, S., Schaefer, R., Bühring, H., Gasser, T., & Biskup, S. (2013) · Movement Disorders · doi:10.1002/mds.25300 · Cited by 81 · cited 1×
“Long-standing evidence intimates a compromised regenerative capacity in the context of NDDs; specifically, an attenuated hematopoietic supplement is observed in patients with AD and PD [57, 58].”
BackgroundTilocca, B., Pieroni, L., Soggiu, A., Britti, D., Bonizzi, L., Roncada, P., & Greco, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114045 · Cited by 81 · cited 2×
“The gut-brain axis (GBA) epitomizes this bidirectional communication, with the gut microbiota acting as a key mediator [102, 103].”
BackgroundRe-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 79 · cited 1×
“…between the peripheral environment and the brain is emerging as a significant factor in the etio-pathogenesis of NDDs. Peripheral cells have been shown to secrete exogenous toxic protein species that can spread to the CNS, potentially instigating or exacerbating neurodegenerative cascades [14].”
BackgroundKatsuda, T., Oki, K., & Ochiya, T. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_98 · Cited by 76 · cited 1×
“Adipose tissue-derived MSCs (AD-MSCs) and their EVs exhibit pronounced neuroprotective effects [94–98].”
BackgroundBone-to-Brain: A Round Trip in the Adaptation to Mechanical Stimuli
Gerosa, L., & Lombardi, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.623893 · Cited by 76 · cited 1×
“For instance, mechanical loading has been shown to revitalize osteocytes and enhance the secretion of EVs derived from them [164, 165].”
BackgroundBeydoun, M. A., Beydoun, H. A., Elbejjani, M., Dore, G. A., & Zonderman, A. B. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.04.009 · Cited by 75
Brain-derived extracellular vesicles promote bone-fat imbalance in Alzheimer's disease
Liu, X., Chen, C., Jiang, Y., Wan, M., Jiao, B., Liao, X., Rao, S., Hong, C., Yang, Q., Zhu, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79461 · Cited by 75 · cited 1×
“Their repertoire extends beyond mere waste disposal to orchestrating physiological and pathological processes, facilitated by their capacity to breach the blood-brain barrier (BBB) and to mediate crosstalk between the CNS and peripheral tissues [7, 8, 11–13].”
BackgroundSelf-citationRole of extracellular vesicles in neurodegenerative diseases
Xiao, Y., Wang, S.-K., Zhang, Y., Rostami, A. M., Kenkare, A., Casella, G., Yuan, Z., & Li, X. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102022 · Cited by 70 · cited 2×
“Their repertoire extends beyond mere waste disposal to orchestrating physiological and pathological processes, facilitated by their capacity to breach the blood-brain barrier (BBB) and to mediate crosstalk between the CNS and peripheral tissues [7, 8, 11–13].”
BackgroundMoy, G. A., & McNay, E. C. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.11.008 · Cited by 65 · cited 1×
“Notably, diets rich in fats and sugars precipitate declines in brain-derived neurotrophic factor (BDNF) expression [90, 91], which is essential for neuronal survival and synaptic integrity.”
BackgroundPeripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 65 · cited 1×
“This is further compounded by documented perturbations in the integrity of the CNS barriers in both ALS rodent models and patients, which potentiate the ingress of noxious peripheral factors into the neural environment [41].”
BackgroundIntercellular and interorgan crosstalk through adipocyte extracellular vesicles
Crewe, C., & Scherer, P. E. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09625-x · Cited by 64 · cited 1×
“These vesicles, harnessing the intrinsic communicative properties of adipocytes, disseminate signals that can be pathogenic or protective, depending on their molecular cargoes and the metabolic context from which they originate [93].”
BackgroundGarcía-Contreras, M., & Thakor, A. S. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00471-7 · Cited by 64 · cited 1×
“In vitro, EVs from human AD-MSCs (hAD-MSCs) mitigate microglial activation and inflammatory cytokine release, simultaneously enhancing anti-inflammatory mediator expression [96].”
BackgroundZhao, L., Ye, Y., Gu, L., Jian, Z., Stary, C. M., & Xiong, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02861-y · Cited by 63 · cited 1×
“These bacterial EVs have emerged as novel communicators within the GBA, traversing to the host brain via circulatory or neural pathways [117, 118].”
BackgroundKwon, H., Lee, E. H., Park, S., Park, J., Hong, J.-H., Kim, E., Shin, T.-S., Kim, Y., & Han, P. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01084-z · Cited by 61
Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology
Zhao, C., Pan, Y., Yu, G., Zhao, X., Chen, X. S., & Rao, L. (2023) · Advanced Materials · doi:10.1002/adma.202207875 · Cited by 60 · cited 1×
“The modification of EV surface ligands represents a critical frontier in this effort [141].”
BackgroundWu, C., Wang, I., Chiang, P., Wang, L., Shen, C.-K. J., & Tsai, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0122-x · Cited by 59
Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
Sun, B., Sawant, H., Borthakur, A., & Bihl, J. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1241418 · Cited by 59 · cited 1×
“These EVs are similar to yet distinct from, mammalian exosomes and ectosomes, as they form through the budding of the bacterial outer membrane [115, 116].”
BackgroundLiu, Z., Li, H., Hong, C., Chen, M., Yue, T., Chen, C., Wang, Z., You, Q., Li, C., Weng, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02647 · Cited by 58 · cited 1×
“Traditional paradigms attribute these phenotypes to an array of cellular malfunctions, including compromised mitochondrial efficacy, oxidative stress, and defective autophagic processes [2–6].”
BackgroundSelf-citationBlood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits
Sun, H.-L., Chen, S.-H., Yu, Z.-Y., Cheng, Y., Tian, D.-Y., Fan, D.-Y., He, C.-Y., Wang, J., Sun, P.-Y., Chen, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0842-1 · Cited by 56 · cited 1×
“This was compellingly demonstrated in a murine model where the transplantation of bone marrow cells from transgenic mice harboring AD-associated mutations into wild type (WT) counterparts resulted in the manifestation of AD-like neuropathology and cognitive deficits [22].”
BackgroundMuscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles
Gall, L. L., Duddy, W. J., Martinat, C., Mariot, V., Connolly, O., Milla, V., Anakor, E., Ouandaogo, Z. G., Millecamps, S., Lainé, J., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12945 · Cited by 55 · cited 1×
“A recent finding accentuates the toxic impact of skeletal muscle-derived EVs from sporadic ALS patients on MNs, under-scoring the direct pathogenic conduits between affected muscles and neuronal cells [43].”
BackgroundKwon, M. J., Kim, J.-H., Kim, J. H., Cho, S. J., Nam, E. S., & Choi, H. G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.786337 · Cited by 54
Wu, X.-P., Wu, X.-P., Xie, H., Zhang, H., Peng, Y.-Z., Yuan, L., Su, X., Luo, X., & Liao, E.-Y. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0943-9 · Cited by 52 · cited 1×
“The attrition of osteocellular vitality, whether through apoptotic demise or dormancy, appears to coincide with a decline in the supportive secretome, implicating bone health as a critical factor in the etiopathogenesis of NDDs [80–82].”
BackgroundSelf-citationInnes, K. E., & Sambamoorthi, U. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191311 · Cited by 52 · cited 1×
“Recent epidemiological threads weave a compelling narrative; diseases deteriorating bone integrity, such as osteoporosis (OP) and osteoarthritis (OA), are correlated with an augmented risk of AD and PD [47, 50–54].”
BackgroundEngineered extracellular vesicles and their mimics in cardiovascular diseases
Lai, J., Huang, C., Guo, Y., & Rao, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.046 · Cited by 49 · cited 1×
“In the vanguard of regenerative medicine and the therapeutic landscape for NDDs, EVs stand out as a promising cell-free modality, circumventing the complexities and ethical quandaries often associated with stem cell transplantation and other cell-based interventions [126].”
BackgroundMaler, J. M., Spitzer, P., Lewczuk, P., Kornhuber, J., i, M. H., & Wiltfang, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001913 · Cited by 47 · cited 1×
“Long-standing evidence intimates a compromised regenerative capacity in the context of NDDs; specifically, an attenuated hematopoietic supplement is observed in patients with AD and PD [57, 58].”
BackgroundPi, Y., Wu, X., Liu, S., Luo, X., Cao, X.-Z., Xie, H., & Liao, E.-Y. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0703-2 · Cited by 46
Self-citationGut Microbiota and Neurologic Diseases and Injuries
Patterson, T. T., & Grandhi, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_6 · Cited by 46 · cited 1×
“Emerging evidence underscores the relationship between microbial dysbiosis and NDD pathogenesis, linking microbial imbalance to CNS anomalies, such as heightened BBB permeability, neuroinflammation, and accumulation of neurotoxic proteins [102, 105].”
BackgroundVatsa, P., Negi, R., Ansari, U. A., Khanna, V., & Pant, A. B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02603-7 · Cited by 45 · cited 2×
“Their autologous use in clinical settings harnesses this natural reservoir of therapeutic agents, offering a promising avenue for the amelioration of NDDs [63, 136].”
BackgroundTransplantation of Nasal Olfactory Mucosa Mesenchymal Stem Cells Benefits Alzheimer’s Disease
Hong, C., Chen, M., Duan, R., Wang, X., Pang, Z., Ge, L., Lü, M., Xie, H., & Liu, Z. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03044-6 · Cited by 45 · cited 1×
“Their autologous use in clinical settings harnesses this natural reservoir of therapeutic agents, offering a promising avenue for the amelioration of NDDs [63, 136].”
BackgroundSelf-citationMechanistic complexities of bone loss in Alzheimer’s disease: a review
Frame, G., Bretland, K. A., & Dengler-Crish, C. M. (2020) · Connective Tissue Research · doi:10.1080/03008207.2019.1624734 · Cited by 44 · cited 1×
“The skeletal system, an often-overlooked contributor to neurodegenerative pathology, dispatches EVs into the peripheral circulation that bears the capacity to influence brain health [45].”
BackgroundMicroglia and Other Myeloid Cells in Central Nervous System Health and Disease
Gopinath, A., Collins, A., Khoshbouei, H., & Streit, W. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265058 · Cited by 44 · cited 1×
“The bone marrow serves as a reservoir for the immune cells, producing a diverse array of components integral to the function of immune system [69].”
BackgroundSheng, Z., Xu, K., Ou, Y., Dai, R.-C., Luo, X., Liu, S., Su, X. Y., Wu, X., Xie, H., Yuan, L., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03941.x · Cited by 42 · cited 1×
“Recent epidemiological threads weave a compelling narrative; diseases deteriorating bone integrity, such as osteoporosis (OP) and osteoarthritis (OA), are correlated with an augmented risk of AD and PD [47, 50–54].”
BackgroundSelf-citationBi, Y. H., Lin, X., Liang, H., Yang, D., Zhang, X., Ke, J., Xiao, J., Chen, Z., Chen, W., Zhang, X., et al. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s259762 · Cited by 40
Garbuzova-Davis, S., Willing, A. E., Ehrhart, J., Wang, L., Sanberg, P. R., & Borlongan, C. V. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08607-1 · Cited by 40 · cited 1×
“Additionally, EPC-derived EVs have been documented to interface with brain endothelial cells, promoting the restoration of the compromised blood-CNS barrier in ALS models [67, 68].”
BackgroundExtracellular Vesicles as a Neprilysin Delivery System Memory Improvement in Alzheimer's Disease.
Izadpanah, M., Dargahi, L., Ai, J., Taei, A. A., Barough, S. E., Mowla, S. J., Tavoosidana, G., & Farahmandfar, M. (2020) · PubMed Central · doi:10.22037/ijpr.2020.112062.13508 · Cited by 40
Yang, Y., Stewart, T., Zhang, C., Wang, P., Xu, Z., Jin, J., Huang, Y. Z., Liu, Z., Lan, G., Liang, X., et al. (2023) · Movement Disorders · doi:10.1002/mds.29620 · Cited by 40
Morales-Prieto, D. M., Murrieta-Coxca, J. M., Stojiljkovic, M., Diezel, C., Streicher, P. E., Henao-Restrepo, J. A., Röstel, F., Lindner, J., Witte, O. W., Weis, S., et al. (2022) · Cells · doi:10.3390/cells11040625 · Cited by 38 · cited 1×
“Experiments demonstrating that blood-transformed EVs from aged mice can provoke glial activation in the brains of younger recipients underscore the profound influence of systemic factors on central pathologies [34].”
BackgroundKaniowska, D., Wenk, K., Rademacher, P., Weiss, R., Fabian, C., Schulz, I., Guthardt, M., Lange, F., Greiser, S., Schmidt, M., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10261-4 · Cited by 38
Hernando, S., Santos‐Vizcaíno, E., Igartúa, M., & Hernández, R. M. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1898 · Cited by 38 · cited 4×
“Conversely, pathological derangements in the BBB, such as those encountered in NDD states, may precipitate a heightened permeability that permits the ingress of neurotoxic EVs, exacerbating neuronal injury [129].”
BackgroundInfluentialLee, J., Ostalecki, C., Oberstein, T. J., Schierer, S., Zinser, E., Eberhardt, M., Blume, K., Plosnita, B., Stich, L., Bruns, H., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103903 · Cited by 35 · cited 2×
“They transport not only the secretases involved in APP processing but also an array of inflammatory mediators [23, 24].”
BackgroundCarata, E., Muci, M., Giulio, S. D., Mariano, S., & Panzarini, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411251 · Cited by 35 · cited 2×
“They are suspected couriers of pathogenic cargo, with a putative role in the dissemination of neurotoxic elements toward motor neurons (MNs) [40, 42].”
BackgroundJin, Y., Wu, R., Li, L., Shen, L., Gu, Y., & Sun, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03179-6 · Cited by 30 · cited 1×
“Moreover, EVs derived from inflamed macrophages (M ϕ ) have been shown to contribute to the progression of PD pathology, intensifying neuroinflammation, and exacerbating disease pathology [35].”
BackgroundSelf-citationAhmed, H. H., Salem, A. M. H., Atta, H. M., Eskandar, E. F., Farrag, A. R. H., Ghazy, M. A., Salem, N. A., & Aglan, H. A. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.106 · Cited by 28 · cited 1×
“Notably, intravenous administration of BM-MSCs has been shown to mitigate pathological alterations and foster neurogenesis within murine models of AD and PD, evincing their regenerative abilities [55, 59, 60].”
BackgroundPark, S., Kim, D., Kim, H., Lee, J., Hwang, D., Kim, T. P., You, S., & Han, D. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137047 · Cited by 28 · cited 1×
“For instance, AD-MSCs cultured in neurogenesis-promoting media have been shown to yield EVs with enhanced neural differentiation potential, indicating that the microenvironmental conditioning of progenitor cells can significantly impact the therapeutic profile of EVs [125].”
BackgroundIyaswamy, A., Lu, K., Guan, X.-J., Kan, Y., Su, C.-F., Liu, J., Jaganathan, R., Vasudevan, K., Paul, J., Thakur, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11072056 · Cited by 28 · cited 2×
“These EVs are similar to yet distinct from, mammalian exosomes and ectosomes, as they form through the budding of the bacterial outer membrane [115, 116].”
BackgroundHuang, T., Jia, Z., Fang, L., Cheng, Z., Qian, J., Xiong, F., Tian, F., & He, X. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.12.015 · Cited by 27 · cited 1×
“Studies by Huang et al. revealed that AD-MSCs subjected to hypoxic conditions not only exhibited increased EV secretion but also an enriched expression of specific microRNAs like miR-511-3p, known for their anti-inflammatory properties [143].”
BackgroundMyeloid extracellular vesicles: messengers from the demented brain
Nigro, A., Colombo, F., Casella, G., Finardi, A., Verderio, C., & Furlan, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00017 · Cited by 26 · cited 2×
“These vesicles carry a payload of bioactive molecules, including cytokines, growth factors, and nucleic acids, that can modulate immune activity within the CNS [70].”
BackgroundEVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
Zhu, Y., Huang, R., Wang, D., Yu, L., Liu, Y., Huang, R., Yin, S., He, X., Chen, B., Liu, Z., et al. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100835 · Cited by 26 · cited 1×
“This has led to successful encapsulation and delivery of therapeutically active molecules like the CB2 receptor agonist AM1241, which exhibits enhanced brain bio-availability and therapeutic efficacy when delivered via MSC-EVs [150].”
BackgroundImpaired brain energy gain upon a glucose load in obesity
Wardzinski, E. K., Kistenmacher, A., Melchert, U. H., Jauch‐Chara, K., & Oltmanns, K. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.013 · Cited by 24 · cited 1×
“However, despite long-term intake of hypercaloric nutrition, the energy status of brain is lowered in obese patients [89].”
BackgroundCao, J., Jin, L., Yan, Z., Wang, X., Li, Y., Wang, Z., Liu, Y.-W., Li, H.-M., Guan, Z., He, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44312-w · Cited by 24 · cited 1×
“These cells are endowed with the remarkable plasticity to self-renew and differentiate into various cell types, thus standing at the fore-front of regenerative medicine and neuroprotection [55, 56].”
BackgroundSelf-citationVilaça-Faria, H., Marote, A., Lages, I., Ribeiro, C., Mendes-Pinheiro, B., Domingues, A. V., Campos, J., Lanceros-Méndez, S., Salgado, A. J., & Teixeira, F. G. (2021) · Biochimie · doi:10.1016/j.biochi.2021.06.008 · Cited by 22 · cited 1×
“Human BM-MSC-derived EVs have further demonstrated their capacity to induce differentiation in neural progenitor cells and have yielded beneficial outcomes in PD animal models, enhancing both motor function and histological integrity [66].”
BackgroundBei, J., Miranda-Morales, E. G., Gan, Q., Qiu, Y., Husseinzadeh, S., Liew, J. Y., Chang, Q., Krishnan, B., Gaitas, A., Yuan, S., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230347 · Cited by 22 · cited 2×
“Additionally, it has also been observed that circulating EVs in AD patients can disrupt the integrity of the BBB by diminishing the expression of vascular endothelial-cadherin, a key adherens junction protein [25].”
BackgroundBone Marrow‐Derived GCA+ Immune Cells Drive Alzheimer's Disease Progression
Zhou, R., Wang, L., Chen, L., Xu, F., Zhou, R., Peng, X. F., Wen, J., Huang, Y., & Zhou, H. (2023) · Advanced Science · doi:10.1002/advs.202303402 · Cited by 20 · cited 1×
“The dichotomy in the role of bone marrow immune cell-derived EVs is stark; while some subsets foster neuroprotection and repair, others may convey pro-inflammatory signals, exacerbating neurodegenerative processes [48, 49].”
BackgroundExtracellular vesicles from dHL-60 cells as delivery vehicles for diverse therapeutics
Kim, J.-K., Youn, Y.-J., Lee, Y.-B., Kim, S.-H., Song, D., Shin, M., Jin, H. K., Bae, J., Shrestha, S., & Hong, C.-W. (2021) · Scientific Reports · doi:10.1038/s41598-021-87891-8 · Cited by 17 · cited 2×
“Such an attribute not only enhances the direct transport of therapeutic cargoes to targeted cells but also augments the therapeutic index of encapsulated drugs [139].”
BackgroundExtracellular vesicle-based therapy for amyotrophic lateral sclerosis
Sadanandan, N., Lee, J.-Y., & Garbuzova-Davis, S. N. (2021) · Brain Circulation · doi:10.4103/bc.bc_9_21 · Cited by 16
Yıldırım, S., Oylumlu, E., Özkan, A., Sinen, O., Bülbül, M., Goksu, E. T., Ertosun, M. G., & Tanrιöver, G. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.05.002 · Cited by 15 · cited 1×
“Adipose tissue-derived MSCs (AD-MSCs) and their EVs exhibit pronounced neuroprotective effects [94–98].”
BackgroundBatabyal, R., Bansal, A., Cechinel, L. R., Authelet, K. J., Goldberg, M., Nadler, E. P., Keene, C. D., Jayadev, S., Domoto‐Reilly, K., Li, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814024 · Cited by 15 · cited 1×
“Furthermore, adipocyte EVs isolated from AD patients carry miRNAs (for example, miR-6760-3p and miR-6798-3p) that may perturb the cyclic AMP response element binding protein (CREB) signaling pathway in neurons, pivotal for memory and synaptic plasticity [100].”
BackgroundKhedher, M. R. B., Haddad, M., Fülöp, T., Laurin, D., & Ramassamy, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230823 · Cited by 9 · cited 1×
“They transport not only the secretases involved in APP processing but also an array of inflammatory mediators [23, 24].”
BackgroundMyeloid Responses to Extracellular Vesicles in Health and Disease
Makhijani, P., & McGaha, T. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.818538 · Cited by 8 · cited 2×
“The dichotomy in the role of bone marrow immune cell-derived EVs is stark; while some subsets foster neuroprotection and repair, others may convey pro-inflammatory signals, exacerbating neurodegenerative processes [48, 49].”
Background
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Malaguarnera, M., & Cabrera‐Pastor, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810068 · Cited by 55
“To improve the targeting efficacy of EVs, they commonly undergo engineering modifications prior to administration, signifying promising research in the EV therapy for CNS disorders [131].”
BackgroundBone-brain interaction: mechanisms and potential intervention strategies of biomaterials
Yu, J., Ji, L., Liu, Y., Wang, X., Wang, J., & Liu, C. (2025) · Bone Research · doi:10.1038/s41413-025-00404-5 · Cited by 34
“205 This feature is harnessed in in fl ammation-targeted technologies that coat nanoparticles with neutrophil membranes.”
The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Conceição, A. R., Marinatto, J., Pinheiro, L. S., Rody, T., & Felice, F. G. D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70209 · Cited by 16
Bidirectional communication between the gut microbiota and the central nervous system
Liu, Y., Tang, T., Cai, H., & Liu, Z. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00434 · Cited by 17
Metadata
- Authors
- Liu, X., Shen, L., Wan, M., Xie, H., & Wang, Z.
- Affiliations
- Central South University (CN)
- Corresponding author
- Xie, Hui
- Venue
- Journal of Nanobiotechnology
- Published
- 2024-04-12
- Volume
- 22
- Issue
- 1
- Pages
- 170-170
- ISSN
- 1477-3155 (ISSN-L)
- PMC
- PMC11015679
- OpenAlex
- W4394748794
- Cited by
- 33
- References
- 165
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 4
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Nanobiotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82301625; 81801395; 82125023; 82072504; 81871822; U22A20300, 81971029)
- National Key R&D Program of China (2020YFC2008500)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- extracellular vesicles, neurodegenerative diseases, blood-brain barrier, drug delivery, gut microbiota, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, exosomes, outer membrane vesicles, osteoporosis, metabolic syndrome, gut dysbiosis
- MeSH terms
- Extracellular Vesicles, Alzheimer Disease, Humans, Parkinson Disease, Prospective Studies, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.